Endpoint-managed photocoagulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9101447
APP PUB NO 20130103008A1
SERIAL NO

13278066

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Systems and processes are described relating to laser-based ophthalmic intervention technologies and, more specifically, to techniques for delivering reproducible amounts of laser energy to create visible and sub-visible lesions on an eye. The subject technology may provide a user with the ability to adjust the amount of energy to be delivered to the eye tissue by selecting a single numerical value. In response, the system may adjust the power and/or duration of the laser treatment beam pulse according to an operating curve determined by the system.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IRIDEX CORPORATION1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sramek, Chris Sunnyvale, US 7 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 11, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00